Humans normally have 46 chromosomes in each cell, divided into 23
pairs. Two copies of chromosome 5, one copy inherited from each parent,
form one of the pairs. Chromosome 5 spans about 181 million DNA building
blocks (base pairs) and represents almost 6 percent of the total DNA in
cells.
Identifying genes on each chromosome is an active area of genetic research. Because researchers use different approaches to predict the number of genes on each chromosome, the estimated number of genes varies. Chromosome 5 likely contains about 900 genes that provide instructions for making proteins. These proteins perform a variety of different roles in the body.
Genes on chromosome 5 are among the estimated 20,000 to 25,000 total genes in the human genome.
Identifying genes on each chromosome is an active area of genetic research. Because researchers use different approaches to predict the number of genes on each chromosome, the estimated number of genes varies. Chromosome 5 likely contains about 900 genes that provide instructions for making proteins. These proteins perform a variety of different roles in the body.
Genes on chromosome 5 are among the estimated 20,000 to 25,000 total genes in the human genome.
How are changes in chromosome 5 related to health conditions?
Many genetic conditions are related to changes in particular genes on chromosome 5.
This list of disorders associated with genes on chromosome 5 provides links to additional information.
Changes in the structure or number of copies of a chromosome can also cause problems with health and development. The following chromosomal conditions are associated with such changes in chromosome 5.
Changes in the structure or number of copies of a chromosome can also cause problems with health and development. The following chromosomal conditions are associated with such changes in chromosome 5.
- cancers
-
Changes in the structure of chromosome 5 are associated with certain
forms of cancer and conditions related to cancer. These changes are
typically somatic, which means they are acquired during a person's
lifetime and are present only in tumor cells. Deletions in the long (q)
arm of the chromosome have been identified in a form of blood cancer
known as acute myeloid leukemia (AML). These deletions also frequently
occur in a disorder called myelodysplastic syndrome, which is a disease
of the blood and bone marrow. People with this condition have a low
number of red blood cells (anemia) and an increased risk of developing
AML. When MDS is associated with a specific deletion in the long arm of
chromosome 5, it is known as 5q- (5q minus) syndrome.
Studies suggest that some genes on chromosome 5 play critical roles in the growth and division of cells. When segments of the chromosome are deleted, as in some cases of AML and MDS, these important genes are missing. Without these genes, cells can grow and divide too quickly and in an uncontrolled way. Researchers are working to identify the specific genes on chromosome 5 that are related to AML and MDS.
- cri-du-chat syndrome
-
Cri-du-chat (cat's cry) syndrome is caused by a deletion of the end
of the short (p) arm of chromosome 5. This chromosomal change is written
as 5p- (5p minus). The signs and symptoms of cri-du-chat syndrome are
probably related to the loss of multiple genes in this region.
Researchers are working to determine how the loss of these genes leads
to the features of the disorder. They have discovered that in people
with cri-du-chat syndrome, larger deletions tend to result in more
severe intellectual disability and developmental delays than smaller
deletions. Researchers have also defined regions of the short arm of
chromosome 5 that are associated with particular features of cri-du-chat
syndrome. A specific region designated 5p15.3 is associated with a
cat-like cry, and a nearby region called 5p15.2 is associated with
intellectual disability, small head size (microcephaly), and distinctive
facial features.
- Crohn disease
-
Several regions of chromosome 5 have been associated with the risk of
developing Crohn disease. For example, a combination of genetic
variations in a region of DNA on the long (q) arm of the chromosome
(5q31) has been shown to increase a person's chance of developing Crohn
disease. Together, these variations are known as the inflammatory bowel
disease 5 (IBD5) locus. This region of chromosome 5 contains several
related genes that may influence Crohn disease risk, including SLC22A4 and SLC22A5.
Variations in a region of the short (p) arm of chromosome 5 designated 5p13.1 are also associated with Crohn disease risk. Researchers refer to this part of chromosome 5 as a "gene desert" because it contains no known genes; however, it may contain stretches of DNA that help regulate nearby genes such as PTGER4. Research studies are under way to examine a possible connection between the PTGER4 gene and Crohn disease.
- PDGFRB-associated chronic eosinophilic leukemia
-
Translocations involving chromosome 5 are involved in a type of blood cell cancer called PDGFRB-associated
chronic eosinophilic leukemia. This condition is characterized by an
increased number of eosinophils, a type of white blood cell. The most
common translocation that causes this condition fuses part of the PDGFRB gene from chromosome 5 with part of the ETV6 gene from chromosome 12, written as t(5;12)(q31-33;p13). Translocations fusing the PDGFRB gene with one of more than 20 other genes have also been found to cause PDGFRB-associated
chronic eosinophilic leukemia, but these other genetic changes are
relatively uncommon. These translocations are acquired during a person's
lifetime and are present only in cancer cells. This type of genetic
change, called a somatic mutation, is not inherited.
The protein produced from the ETV6-PDGFRB fusion gene, called ETV6/PDGFRβ, functions differently than the proteins normally produced from the individual genes. The ETV6 protein normally turns off (represses) gene activity and the PDGFRβ protein plays a role in turning on (activating) signaling pathways. The ETV6/PDGFRβ protein is always turned on, activating signaling pathways and gene activity. When the ETV6-PDGFRB fusion gene mutation occurs in cells that develop into blood cells, the growth of eosinophils (and occasionally other white blood cells, such as neutrophils and mast cells) is poorly controlled, leading to PDGFRB-associated chronic eosinophilic leukemia. It is unclear why eosinophils are preferentially affected by this genetic change.
- periventricular heterotopia
-
In a few cases, abnormalities in chromosome 5 have been associated
with periventricular heterotopia, a disorder characterized by abnormal
clumps of nerve cells (neurons) around fluid-filled cavities
(ventricles) near the center of the brain. In each case, the affected
individual had extra genetic material caused by an abnormal duplication
of part of this chromosome. It is not known how this duplicated genetic
material results in the signs and symptoms of periventricular
heterotopia.
- other chromosomal conditions
-
Other changes in the number or structure of chromosome 5 can have a
variety of effects, including delayed growth and development,
distinctive facial features, birth defects, and other health problems.
Changes to chromosome 5 include an extra segment of the short (p) or
long (q) arm of the chromosome in each cell (partial trisomy 5p or 5q), a
missing segment of the long arm of the chromosome in each cell (partial
monosomy 5q), and a circular structure called ring chromosome 5. Ring
chromosomes occur when a chromosome breaks in two places and the ends of
the chromosome arms fuse together to form a circular structure.
No comments:
Post a Comment